跳至主要内容
临床试验/JPRN-UMIN000016621
JPRN-UMIN000016621招募中未知

Effects of Shin'iseihaito in asthma patients with upper airway disease - Effects of Shin'iseihaito in asthma patients with upper airway disease

Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital0 个研究点目标入组 30 人开始时间: 2015年2月25日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) hypersensitivity of the harbal medicine included in Shin'iseihaito. (2) interstitial pneumonia (3) Liver dysfunction; more than 2.0mg/dl of T-Bil or more than 100IU/l of transaminase. (4) treated with systemic steroid or anti-IgE antibody or the harbal medicine included in Shin'iseihaito. (5) pregnant or nursing or planning of pregnancy. (6) the change of medication or surgical treatment are scheduled during study period.

研究者

发起方
Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital

相似试验